HB
Harold Bernstein sold $426K of MAZE stock
Harold Bernstein, President, R&D & CMO of Maze Therapeutics, Inc. (MAZE), sold 16,141 shares of MAZE stock worth $426K, per an SEC Form 4 filed Sep 3, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Sep 1, 2026, 2 days before it was made public.
MAZE has moved +22.2% since the trade date, from $26.53 to $32.43 (Nov 19, 2026 close).
- Traded
- Sep 1, 2026
- Disclosed
- Sep 3, 2026
- Filing delay
- 2 days
- Price since
- +22.2%
- Role
- President, R&D & CMO
- Source
- SEC Form 4